Drug profile · INN
sucralfate
SUCRALFATE
sucralfate (SUCRALFATE) is a pepsin a inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — sucralfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
sucralfate (SUCRALFATE) is a pepsin a inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Pepsin A inhibitor
Primary target: Glycoproteins
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is sucralfate?
sucralfate (SUCRALFATE) is a pepsin a inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sucralfate?
SUCRALFATE is a marketed brand name for sucralfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sucralfate?
sucralfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.